000 01319 a2200361 4500
005 20250513211552.0
264 0 _c20000512
008 200005s 0 0 eng d
022 _a0969-7128
024 7 _a10.1038/sj.gt.3301133
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBenvenuti, F
245 0 0 _aAnti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
_h[electronic resource]
260 _bGene therapy
_cApr 2000
300 _a605-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Anti-Idiotypic
_xgenetics
650 0 4 _aCell Line
650 0 4 _aDNA Fingerprinting
_xmethods
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aGenetic Engineering
_xmethods
650 0 4 _aImmunoglobulin Variable Region
_xgenetics
650 0 4 _aLymphoma
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aTransfection
_xmethods
650 0 4 _aVaccines, DNA
_xadministration & dosage
700 1 _aBurrone, O R
700 1 _aEfremov, D G
773 0 _tGene therapy
_gvol. 7
_gno. 7
_gp. 605-11
856 4 0 _uhttps://doi.org/10.1038/sj.gt.3301133
_zAvailable from publisher's website
999 _c10771263
_d10771263